1. Home
  2. BCYC vs EXK Comparison

BCYC vs EXK Comparison

Compare BCYC & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • EXK
  • Stock Information
  • Founded
  • BCYC 2009
  • EXK 1981
  • Country
  • BCYC United Kingdom
  • EXK Canada
  • Employees
  • BCYC N/A
  • EXK N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • EXK Precious Metals
  • Sector
  • BCYC Health Care
  • EXK Basic Materials
  • Exchange
  • BCYC Nasdaq
  • EXK Nasdaq
  • Market Cap
  • BCYC 896.2M
  • EXK 920.7M
  • IPO Year
  • BCYC 2019
  • EXK N/A
  • Fundamental
  • Price
  • BCYC $11.66
  • EXK $3.83
  • Analyst Decision
  • BCYC Buy
  • EXK Strong Buy
  • Analyst Count
  • BCYC 9
  • EXK 3
  • Target Price
  • BCYC $33.25
  • EXK $6.75
  • AVG Volume (30 Days)
  • BCYC 295.8K
  • EXK 9.8M
  • Earning Date
  • BCYC 03-04-2025
  • EXK 03-11-2025
  • Dividend Yield
  • BCYC N/A
  • EXK N/A
  • EPS Growth
  • BCYC N/A
  • EXK N/A
  • EPS
  • BCYC N/A
  • EXK N/A
  • Revenue
  • BCYC $36,898,000.00
  • EXK $225,927,000.00
  • Revenue This Year
  • BCYC $41.07
  • EXK $8.33
  • Revenue Next Year
  • BCYC N/A
  • EXK $60.97
  • P/E Ratio
  • BCYC N/A
  • EXK N/A
  • Revenue Growth
  • BCYC 48.60
  • EXK N/A
  • 52 Week Low
  • BCYC $11.14
  • EXK $1.42
  • 52 Week High
  • BCYC $28.67
  • EXK $5.67
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 34.58
  • EXK 47.10
  • Support Level
  • BCYC $11.14
  • EXK $3.90
  • Resistance Level
  • BCYC $13.11
  • EXK $4.22
  • Average True Range (ATR)
  • BCYC 0.69
  • EXK 0.22
  • MACD
  • BCYC 0.08
  • EXK -0.00
  • Stochastic Oscillator
  • BCYC 22.32
  • EXK 1.69

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

About EXK Endeavour Silver Corporation (Canada)

Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The company has three producing silver-gold mines in Mexico: the Guanacevi Mine in Durango, the Bolanitos Mine in Guanajuato and the El Compas Mine in Zacatecas. It also has three exploration projects in northern Chile: Aida project, Paloma project and the Cerro Marquez project.

Share on Social Networks: